Related Experiment Video
Updated: Feb 4, 2026
Murine Fetal Echocardiography
Published on: February 15, 2013
Echocardiography in Sarcoidosis
Reto Kurmann1,2, Sunil V Mankad3, Rekha Mankad1
1Department of Cardiology, Mayo Clinic, Rochester, MN, USA.
Insights
Diagnosing cardiac sarcoidosis (CS) is difficult, often requiring advanced imaging. Early detection through echocardiography and other techniques is crucial for reducing mortality from this challenging heart condition.
Area of Science:
- Cardiology
- Medical Imaging
- Immunology
Background:
- Cardiac sarcoidosis (CS) presents diagnostic challenges, often considered after other conditions are excluded.
- A high index of suspicion is crucial for appropriate diagnostic testing for CS.
- Transthoracic echocardiography is a primary imaging tool, but lacks pathognomonic features for CS.
Purpose of the Study:
- To review the diagnostic challenges and imaging modalities for cardiac sarcoidosis.
- To highlight the role of echocardiography and advanced imaging in CS diagnosis.
- To emphasize the importance of early diagnosis for improving patient outcomes.
Main Methods:
- Review of echocardiographic findings, including wall motion abnormalities and strain imaging.
- Discussion of alternative imaging techniques like cardiac MRI and PET.
- Consideration of endomyocardial biopsy's limitations (specificity vs. sensitivity).
Main Results:
- Unusual wall motion abnormalities and diastolic dysfunction on echocardiography can suggest CS.
- Myocardial strain imaging may enhance echocardiographic sensitivity for CS detection.
- Cardiac MRI and PET are increasingly used, complementing echocardiography in CS diagnosis.
Conclusions:
- Cardiac sarcoidosis diagnosis remains challenging, necessitating a multi-modality imaging approach.
- Early diagnosis is critical for mitigating the high morbidity and mortality associated with CS.
- While echocardiography is a cornerstone, its limitations drive the use of advanced imaging and biopsy for definitive diagnosis and follow-up.
Purpose Of Review:
Cardiac sarcoidosis (CS) is associated with significant morbidity and mortality. The diagnosis of CS is challenging and typically one that is only entertained after many other conditions have been ruled out. A high index of suspicion is necessary in order to correctly determine appropriate testing for the disease. Transthoracic echocardiography is the most readily available imaging modality available to help establish a diagnosis in a potential patient. However, no one echocardiographic feature is pathognomonic.
Recent Findings:
On echocardiography, unusual wall motion abnormalities, which do not fit a classic coronary distribution, along with diastolic dysfunction may alert one to the presence of cardiac sarcoid, particularly in the right clinical context. Myocardial strain imaging on echocardiography may increase the sensitivity of identifying cardiac sarcoidosis. Alternative imaging with cardiac magnetic resonance imaging or positron emission tomography have become more frequently utilized to establish a diagnosis of CS. Cardiac sarcoidosis remains a difficult condition to diagnose. However early diagnosis is critical to decrease the associated high mortality. Endomyocardial biopsy is highly specific but lacks sensitivity due to the patchy nature of the granulomatous deposition. Thus, imaging plays a role in diagnosis as well as for follow-up. Echocardiography remains an hallmark during the workup for CS. Decreased sensitivity of echocardiography has facilitated the use of other techniques to establish the presence of CS.
